Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines

Journal of Molecular Endocrinology

Volumn 42, Issue 3, 2009, Pages 249-260

  Trojanowicz, Bogusz ^a   Winkler, Anja ^a   Hammje, Kathrin ^a   Chen, Zhouxun ^a   Sekulla, Carsten ^a   Glanz, Dagobert ^b   Schmutzler, Cornelia ^c   Mentrup, Birgit ^d   Hombach Klonisch, Sabine ^e   Klonisch, Thomas ^e   Finke, Rainer ^a   Köhrle, Josef ^c   Dralle, Henning ^a   Hoang Vu, Cuong ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA ENOLASE; ALPHA ENOLASE A1; ALPHA ENOLASE A2; ALPHA ENOLASE A3; ENOLASE; MYC PROTEIN; PHOSPHOPROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MBP1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENO1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL LEVEL; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENETIC REGULATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; THYROID FOLLICULAR CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; APOPTOSIS; CELL MOTION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; THYROID TUMOR; TUMOR CELL LINE;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHOPYRUVATE HYDRATASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYROID NEOPLASMS; TRETINOIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 64549112704     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0118     Document Type: Article

References (46)

1. Akie K, Dosaka-Akita H, Murakami A & Kawakami Y 2000 A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Antisense & Nucleic Acid Drug Development 10 243-249.
2. Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F et al. 2004 Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. Journal of Clinical Endocrinology and Metabolism 89 994-1005.
3. Biesalski HK & Nohr D 2003 Importance of vitamin-A for lung function and development. Molecular Aspects of Medicine 24 431-440.
4. Buletic Z, Soprano KJ & Soprano DR 2006 Retinoid targets for the treatment of cancer. Critical Reviews in Eukaryotic Gene Expression 16 193-210.
5. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P & Degos L 1990 All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76 1704-1709.
6. Chang YS, Wu W, Walsh G, Hong WK & Mao L 2003 Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clinical Cancer Research 9 3641-3644.
7. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC et al. 2006 Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clinical Cancer Research 12 5746-5754.
8. Chanson A, Cardinault N, Rock E, Martin JF, Souteyrand P, D'Incan M & Brachet P 2008 Decreased plasma folate concentration in young and elderly healthy subjects after a short-term supplementation with isotretinoin. Journal of the European Academy of Dermatology and Venereology 22 94-100.
9. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K & Oberg F 2002 Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99 2199-2206.
10. Ebert W, Muley T & Drings P 1996 Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Research 16 2161-2168.
11. Feo S, Arcuri D, Piddini E, Passantino R & Giallongo A 2000 ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Letters 473 47-52.
12. Fex GA, Aronsson A, Andersson A, Larsson K & Nilsson-Ehle P 1996 In vivo effects of 13-cis retinoic acid treatment on the concentration of proteins and lipids in serum. European Journal of Clinical Chemistry and Clinical Biochemistry 34 3-7.
13. Giallongo A, Oliva D, Calì L, Barba G, Barbieri G & Feo S 1990 Structure of the human gene for alpha-enolase. European Journal of Biochemistry 190 567-573.
14. Gianni M, Kopf E, Bastien J, Oulad-Abdelghani M, Garattini E, Chambon P & Rochette-Egly C 2002 Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2. Journal of Biological Chemistry 277 24859-24862.
15. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ & De Luca LM 2000 Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21 1271-1279.
16. Hong WK & Itri LM 1994 Retinoids and human cancer. In The Retinoids, pp 597-658. Eds MB Sporn, AB Roberts & DS Goodman. New York, NY: Raven Press.
17. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ & Wang ZY 1988 Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72 567-572.
18. Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF & Yi H 2006 Proteomic analysis of secreted proteins of non-small cell lung cancer. Ai Zheng 25 1361-1367.
19. Joseph J, Cruz-Sanchez FF & Carreras J 1996 Enolase activity and isoenzyme distribution in human brain regions and tumors. Journal of Neurochemistry 66 2484-2490.
20. Kaiser E, Kuzmits R, Pregant P, Burghuber O & Worofka W 1989 Clinical biochemistry of neuron specific enolase. Clinica Chimica Acta 183 13-31.
21. Kalemkerian GP, Jasti RK, Celano P, Nelkin BD & Mabry M 1994 All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth and Differentiation 5 55-60.
22. Kato K, Asai R, Shimizu A, Suzuki F & Ariyoshi Y 1983 Immunoassay of three enolase isozymes in human serum and in blood cells. Clinica Chimica Acta 127 353-363.
23. Ledermann JA 1994 Serum neurone-specific enolase and other neuroendocrine markers in lung cancer. European Journal of Cancer 30 574-576.
24. Lengfelder E, Saussele S, Weisser A, Buchner T & Hehlmann R 2005 Treatment concepts of acute promyelocytic leukemia. Critical Reviews in Oncology/Hematology 56 261-274.
25. Maden M 2000 The role of retinoic acid in embryonic and post-embryonic development. Proceedings of the Nutrition Society 59 65-73.
26. Matsuoka Y, Nagahara Y, Ikekita M & Shinomiya T 2003 A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. British Journal of Pharmacology 138 1303-1312.
27. Merkulova T, Dehaupas M, Nevers MC, Creminon C, Alameddine H & Keller A 2000 Differential modulation of alpha, beta and gamma enolase isoforms in regenerating mouse skeletal muscle. European Journal of Biochemistry 267 3735-3743.
28. Moriyama K, Iida K & Yahara I 1996 Phosphorylation of Ser-3 of cofilin regulates its essential function on actin. Genes to Cells 1 73-86.
29. Niklinski J & Furman M 1995 Clinical tumour markers in lung cancer. European Journal of Cancer Prevention 4 129-138.
30. Niles RM 2000 Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16 1084-1089.
31. Pancholi V 2001 Multifunctional alpha-enolase: its role in diseases. Cellular and Molecular Life Sciences 58 902-920.
32. Redlitz A, Fowler BJ, Plow EF & Miles LA 1995 The role of an enolase-related molecule in plasminogen binding to cells. European Journal of Biochemistry 227 407-415.
33. Royds JA, Parsons MA, Taylor CB & Timperley WR 1982 Enolase isoenzyme distribution in the human brain and its tumours. Journal of Pathology 137 37-49.
34. Schmutzler C & Kohrle J 2000 Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 10 393-406.
35. Schmutzler C, Hoang-Vu C, Rüger B & Kohrle J 2004 Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. European Journal of Endocrinology 150 547-556.
36. Simon D, Koehrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K, Goretzki PE & Roeher HD 1998 Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma. World Journal of Surgery 22 569-574.
37. Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R, Grünwald F, Müller-Gärtner HW, Schmutzler C, Köhrle J et al. 2002 Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. European Journal of Nuclear Medicine and Molecular Imaging 29 775-782.
38. Subramanian A & Miller DM 2000 Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. Journal of Biological Chemistry 275 5958-5965.
39. Sueoka N, Lee HY, Walsh GL, Hong WK & Kurie JM 1999 Posttranslational mechanisms contribute to the suppression of specific cyclin: CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Cancer Research 59 3838-3844.
40. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Okita K, Oka M & Nakamura K 2005 Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5 1686-1692.
41. Towle HC 1995 Metabolic regulation of gene transcription in mammals. Journal of Biological Chemistry 270 23235-23238.
42. Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M & Dimmeler S 2002 Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB Journal 16 706-708.
43. Verma AK 1987 Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Research 47 5097-5101.
44. Vervoorts J, Lüscher-Firzlaff J & Lüscher B 2006 The ins and outs of MYC regulation by posttranslational mechanisms. Journal of Biological Chemistry 281 34725-34729.
45. Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS et al. 2006 Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. International Journal of Oncology 29 315-327.
46. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK & Koay ES 2005 Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Molecular and Cellular Proteomics 4 1686-1696.